View drug registration information details.


ItemsRegistration information
ID323
No323
Brand NameKETOCONAZOLE TABLET 200 MG
IngredientsKETOCONAZOLE 200 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
StorageSTORE BELOW 30 C, PROTECT FROM LIGHT
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationJ02AB02
Pharmaceutical ClassANTIFUNGAL
IndicationsTREATMENT OF THE FOLLOWING SYSTEMIC FUNGAL INFECTIONS IN PATIENTS WHO HAVE FAILED OR WHO ARE INTOLERANT TO OTHER THERAPIES:BLASTOMYCOSIS, COCCIDIOIDOMYCOSIS, HISTOPLASMOSIS, CHROMOMYCOSIS AND PARACOCCIDIOIDOMYCOSIS
ContraindicationsIN PATIENTS WITH ACUTE OR CHRONIC LIVER DISEASE OR WITH A KNOWN HYPERSENSITIVITY, WHEN CO-ADMINISTERED WITH TERFENADINE, ASTEMIZOLE AND CISAPRIDE.
Side EffectsHEPATITIS, HYPERSENSITIVITY, SKIN RASH, PRURITUS, DIARRHEA, NAUSEA, VOMITTING, CONSTIPATION, ABDOMINAL PAIN, DIZZINESS, DROWNSINESS, HEADACHE, GYNAECOMASTIA, IMPOTENCE, MENSTRUAL IRREGULARITIES, PHOTOPHOBIA, SOMNOLENCE, THROMBOCYTOPENIA,
Unit Price6.1
EDL Yes
DescriptionROUND, 10 MM IN DIAMETER, WHITE UNCOATED TABLET, BEVEL-EDGED, SHALLOW CONVEX FACES, HD AND BREAK-BAR EMBOSSED ON ONE FACE
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration NoMAL19987375AZ
Import Registration Date28/09/2013
ActivityCERTIFICATE RELEASED
Applied Date2022-03-29
FDD Registration No05 I 4705/19
FDD Registration Date2022-09-08
Expiry Date2025-09-07

Back to drug list